Industrial Info to Present Webinar on Global Pharmaceutical-Biotech Project Outlook
Industrial Info will present a complimentary webinar on the global Pharmaceutical-Biotech project outlook on July 11, 2018, at 9 a.m. CDT (10 a.m. EDT). Join Annette Kreuger, Industrial Info's vice president of Pharmaceutical-Biotech Industry research, and Shaheen Chohan, vice president of global analytics, as they discuss the future of the industry. Industrial Info is tracking $149 billion in active Pharmaceutical-Biotech projects across the world, including more than $76 billion in North America.
Examples of projects being tracked by Industrial Info include Novo Nordisk AS' (NYSE:NVO) (Bagsværd, Denmark) massive grassroot insulin active pharmaceutical ingredient (API) in Clayton, North Carolina. Construction on the $1.8 billion plant began in late 2016, with Fluor Corporation (NYSE:FLR) (Irving, Texas) providing engineering, procurement and construction. The project is expected to wrap up in 2020. For more information, see Industrial Info's project report.
The webinar will cover the following topics and more:
- How location dictates project purpose
- Demonstrations of spending by industry segment
- A focus on key market drivers influencing future spending
- Capital spending by project type
"As the Pharmaceutical-Biotech Industry continues its sprawl across the globe, the types of projects being built are influenced by where they will be located," said Kreuger. "The $149 billion in reported potential project spend includes everything from $1 million dollar scheduled maintenance projects to $2 billion grassroot advanced biological manufacturing plants. We will offer insight as to what types of projects are making it from the drawing board to construction, as well as today's industry drivers and trends."
Join Industrial Info July 11 for the webinar. Make sure to RSVP today!